In Pharma Sustainability, AstraZeneca, Johnson & Johnson Rate High
On a scale of 1 to 100, AstraZeneca and Johnson & Johnson are the only pharmaceutical companies to rate above 70 in a recent survey of sustainability practices in the sector.
Other firms scoring highly are Baxter (66) and GlaxoSmithKline, Pfizer and Schering-Plough, all three of which scored 60.
Climate Counts evaluates firms’ commitments in four areas:
- whether they have measured their carbon footprint
- if they reduced their impact on global warming
- if they have supported or blocked climate legislation or policy
- to what level they have publicly disclosed their climate actions
AstraZeneca scored highly in all sectors except for policy, in which it scored a zero out of ten.
Johnson & Johnson scored highly in all sectors except for measuring its own carbon footprint, an area in which it scored 12 out of 22.
Energy Manager News
- Smart Windows are a Smart Idea
- Behind the Meter Podcast: The Telecommunications Industry Addresses Energy Challenges
- Ambitious Goals for The Boulder Valley SD
- Philips, Cisco, Alliander Bringing Smart Lighting to Amsterdam
- TCAP to Negotiate Five-Year Electric Rates for Sherman, Texas
- Quality Power, Not Just Power, Should be the Goal
- Siemens Unveils Microgrid-as-a-Service Platform
- 18 Buildings Going Solar in D.C.